PAM
PHIO icon

Panagora Asset Management’s Phio Pharmaceuticals PHIO Stock Holding History

Panagora Asset Management’s Portfolio PHIO Stock Details PHIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-1
Closed -$34K – 2344
2017
Q3 		$34K Hold
1
– – ﹤0.01% 2116
2017
Q2 		$50K Buy
+1
New +$37K ﹤0.01% 2068
2017
Q1 		– Hold
0
– – – 2329

Other funds holding PHIO

TSS
Two Sigma Securities New York $1.16B AUM 36.23% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
VF
Virtu Financial New York $3.18B AUM 65.92% 1-Year Est. Return
IP
Intellectus Partners San Francisco, California $578M AUM 49.48% 1-Year Est. Return
RJFSA
Raymond James Financial Services Advisors St. Petersburg, Florida $75.1B AUM 31.89% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Panagora Asset Management's PHIO Position: Q4 2017 in Review

Panagora Asset Management sold out of Phio Pharmaceuticals (PHIO) in Q4 2017, closing a stake of 1 share — an estimated $34K sold.

Panagora Asset Management first reported a position in PHIO in Q2 2017 and held it in 2 quarters. The position peaked at $50K in Q2 2017. 2 funds tracked by Wall St. Rank hold PHIO as of Q4 2017.

  • Panagora Asset Management reported no remaining Phio Pharmaceuticals position as of Q4 2017 after selling out during the quarter.
  • Panagora Asset Management sold 1 Phio Pharmaceuticals share in Q4 2017, an estimated $34K.
  • Panagora Asset Management first reported a position in Phio Pharmaceuticals in Q2 2017 and held it in 2 quarters.
  • Panagora Asset Management's Phio Pharmaceuticals position peaked at $50K in Q2 2017.
  • 2 funds tracked by Wall St. Rank held Phio Pharmaceuticals as of Q4 2017.

Based on Panagora Asset Management's 13F filing for Q4 2017, filed 14 Feb 2018.